Endocrine Society releases new guidelines for the pharmacological management of osteoporosis in postmenopausal women.
Endocrine Society updates osteoporosis management guidelines for postmenopausal women
Recent studies show that replaced hips typically last 25 years or longer
Many individuals that take steroids for chronic inflammatory conditions get osteoporosis; Prolia now FDA approved for Rx
Evenity (romosozumab) a novel precision medicine moves closer to FDA approval as a treatment option for osteoporosis.
Research suggests Thalassemia patients osteoporosis can be improved with Prolia
Study highlights the importance of non discontinuing medications to treat osteoporosis
Dr David Borenstein discusses results of recent study suggesting Vertebroplasty is ineffective.
Eileen Lydon ANP, NYU Hospital For Joint Diseases Discusses Risk of Osteoporosis in RA and PsA
Assisted devices can help make everyday life a little bit easier and help you to maintain your independence.
Should'nt the leading total health & wellness resource be delivered to your home or office?
Understand the administration, side effects and answers to frequently asked questions about Evista.
Studies show reductions in fracture risks during the first three to four years but little or no longer term benefit.
Laura Ryan, MD, of The Ohio State University Wexner Medical Center Discusses What Should Women Know about Osteoporosis
A list of key questions individuals should ask when selecting a doctor to consider joint replacement surgery.
Understand the administration, side effects and answers to frequently asked questions about Evista (raloxifene)
10 million Americans live with osteoporosis, and 44 million are at increased risk. How can patients be diagnosed?
Understand the administration, side effects and answers to frequently asked questions about Prolia.
Osteoporosis affects 44 million Americans - Understand how and why it occurs and what you can do about it.
Improved understanding of osteoporosis is resulting in better fracture prevention and fewer side effects from treatment.
Osteoporosis is a serious illness associated with significant disability: The ACP has published new guidelines.
Increasing understanding of the condition and its treatment is resulting in better fracture prevention and fewer side ef
When a fracture is identified only a minority of patients receive appropriate treatment to prevent the next fracture.
According to the NOF postmenopausal women under age 65 without risk factors for osteoporosis may not need to be tested.
Long-term bisphosphonate us may increase risk of unusual types of femur fractures in older women